Showing results (1-10 of 94) with videos related to
Sort By:
Pageof 10
European Journal of Immunology|December 27, 2018
XIAP deficiency in hematopoietic recipient cells drives donor T-cell activation and GvHD in miceNicole Müller, Julius C Fischer, Monica Yabal, et al.Oncoimmunology|March 26, 2019
Targeting intrinsic RIG-I signaling turns melanoma cells into type I interferon-releasing cellular antitumor vaccinesSarah Bek, Florian Stritzke, Alexander Wintges, et al.Scientific Reports|October 20, 2019
Type I interferon signaling before hematopoietic stem cell transplantation lowers donor T cell activation via reduced allogenicity of recipient cellsJulius C Fischer, Michael Bscheider, Sascha Göttert, et al.Journal of Molecular Medicine (Berlin, Germany)|April 20, 2010
SYK kinase signaling and the NLRP3 inflammasome in antifungal immunityHendrik Poeck, Jürgen RulandJournal of Clinical Immunology|April 20, 2010
ITAM receptor signaling and the NLRP3 inflammasome in antifungal immunityHendrik Poeck, Jürgen RulandEuropean Journal of Cell Biology|April 13, 2011
From virus to inflammation: mechanisms of RIG-I-induced IL-1β productionHendrik Poeck, Jürgen RulandCancer Research|April 30, 2025
Targeting Intracellular Innate RNA-Sensing Systems Overcomes Resistance to CAR T Cell Therapy in Solid TumorsNardine Soliman, Tatiana Nedelko, Giada Mandracci, et al.European Journal of Immunology|August 24, 2017
A20 deletion in T cells modulates acute graft-versus-host disease in miceJulius C Fischer, Vera Otten, Katja Steiger, et al.International Journal of Radiation Oncology, Biology, Physics|December 4, 2018
Regeneration After Radiation- and Immune-Mediated Tissue Injury Is Not Enhanced by Type III Interferon SignalingJulius C Fischer, Chia-Ching Lin, Simon Heidegger, et al.European Journal of Immunology|March 16, 2017
Card9 controls Dectin-1-induced T-cell cytotoxicity and tumor growth in miceTobias Haas, Simon Heidegger, Alexander Wintges, et al.Pageof 10